Viewing Study NCT02238132


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-01-01 @ 10:31 AM
Study NCT ID: NCT02238132
Status: COMPLETED
Last Update Posted: 2014-09-12
First Post: 2014-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module